Follow
Nicholas R. Larson
Nicholas R. Larson
Verified email at biogen.com
Title
Cited by
Cited by
Year
Comparison of polysorbate 80 hydrolysis and oxidation on the aggregation of a monoclonal antibody
NR Larson, Y Wei, I Prajapati, A Chakraborty, B Peters, C Kalonia, ...
Journal of Pharmaceutical Sciences 109 (1), 633-639, 2020
742020
Glatiramer acetate persists at the injection site and draining lymph nodes via electrostatically-induced aggregation
JY Song, NR Larson, S Thati, I Torres-Vazquez, N Martinez-Rivera, ...
Journal of controlled release 293, 36-47, 2019
292019
Molecular trajectories provide signatures of protein clustering and crowding at the oil/water interface
AC McUmber, NR Larson, TW Randolph, DK Schwartz
Langmuir 31 (21), 5882-5890, 2015
232015
Improved fluorescence methods for high-throughput protein formulation screening
Y Wei, NR Larson, SK Angalakurthi, C Russell Middaugh
SLAS Technology: Translating Life Sciences Innovation 23 (6), 516-528, 2018
212018
Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists
A Zacharia, E Harberts, SM Valencia, B Myers, C Sanders, A Jain, ...
Vaccine 39 (2), 292-302, 2021
202021
Soluble antigen arrays for selective desensitization of insulin-reactive B cells
MA Leon, SM Wemlinger, NR Larson, JK Ruffalo, JO Sestak, ...
Molecular pharmaceutics 16 (4), 1563-1572, 2019
202019
pH-dependent phase behavior and stability of cationic lipid–mRNA nanoparticles
NR Larson, G Hu, Y Wei, AD Tuesca, ML Forrest, CR Middaugh
Journal of Pharmaceutical Sciences 111 (3), 690-698, 2022
172022
Cis/trans isomerization of unsaturated fatty acids in polysorbate 80 during light exposure of a monoclonal antibody–containing formulation
I Prajapati, BH Peters, NR Larson, Y Wei, S Choudhary, C Kalonia, ...
Journal of Pharmaceutical Sciences 109 (1), 603-613, 2020
152020
Label-free, direct measurement of protein concentrations in turbid solutions with a UV–visible integrating cavity absorbance spectrometer
NR Larson, Y Wei, CR Middaugh
Analytical chemistry 90 (8), 4982-4986, 2018
152018
Effect of 2 emulsion-based adjuvants on the structure and thermal stability of staphylococcus aureus alpha-toxin
Y Wei, J Xiong, NR Larson, V Iyer, G Sanyal, SB Joshi, DB Volkin, ...
Journal of pharmaceutical sciences 107 (9), 2325-2334, 2018
122018
Effects of glycan structure on the stability and receptor binding of an IgG4-Fc
H Kang, NR Larson, DR White, CR Middaugh, T Tolbert, C Schöneich
Journal of Pharmaceutical Sciences 109 (1), 677-689, 2020
92020
ACUVRA: Anion-Exchange Chromatography UV-Ratio Analysis—A QC-Friendly Method for Monitoring Adeno-Associated Virus Empty Capsid Content to Support Process Development and GMP …
R Frenkel, D Tribby, B Boumajny, N Larson, M Sampson, C Barney, ...
The AAPS Journal 25 (1), 3, 2022
42022
Rapid high-resolution size distribution protocol for adeno-associated virus using high speed SV-AUC
SA Berkowitz, N Larson, G Bou-Assaf, T Laue
Analytical Biochemistry 689, 115482, 2024
32024
Synthetic Cationic Autoantigen Mimics Glatiramer Acetate Persistence at the Site of Injection and Is Efficacious Against Experimental Autoimmune Encephalomyelitis
JY Song, JD Griffin, NR Larson, MA Christopher, CR Middaugh, ...
Frontiers in Immunology 11, 603029, 2021
32021
Conformational changes and drivers of monoclonal antibody liquid-liquid phase separation
NR Larson, Y Wei, TA Cruz, R Esfandiary, CK Kalonia, ML Forrest, ...
Journal of pharmaceutical sciences 112 (3), 680-690, 2023
22023
Visible Light Degradation of a Monoclonal Antibody in a High-Concentration Formulation: Characterization of a Tryptophan-Derived Chromophoric Photo-product by Comparison to …
I Prajapati, NR Larson, S Choudhary, C Kalonia, S Hudak, R Esfandiary, ...
Molecular Pharmaceutics 18 (9), 3223-3234, 2021
22021
Chapter 7: An Empirical Phase Diagram: High-Throughput Screening Approach to the Characterization and Formulation of Biopharmaceuticals
Y Wei, SB Joshi, A Bhambhani, Y Zeng, NR Larson, G Hu, EJ Deeds, ...
Development of Biopharmaceutical Drug-Device Products, 139-185, 2020
22020
Development of UPLC-UV-ELSD Method for Fatty Acid Profiling in Polysorbate 80 and Confirmation of the Presence of Conjugated Fatty Acids by Mass Spectrometry, UV Absorbance and …
M Doyle, A Barnes, NR Larson, H Liu, L Yi
Journal of Pharmaceutical Sciences 112 (9), 2393-2403, 2023
12023
Establishing stereochemical comparability in phosphorothioate oligonucleotides with nuclease P1 digestion coupled with LCMS analysis
Z Li, F Tong, L Xiao, NR Larson, X Zhou, Y Zhang, JP Immel-Brown, ...
Analyst 148 (21), 5361-5365, 2023
12023
Subunit-based vaccines: challenges in developing protein-based vaccines
SF Ausar, NR Larson, Y Wei, A Jain, CR Middaugh
Practical Aspects of Vaccine Development, 79-135, 2022
12022
The system can't perform the operation now. Try again later.
Articles 1–20